---
title: "Guidance on significant changes regarding the transitional provision"
url: https://normiq.app/en/regulations/mdcg-2020-3
language: en
updated: 2026-09-03
---

# Guidance on significant changes regarding the transitional provision

MDCG 2020-3

Defines the significant changes that require a new MDR conformity assessment

- [Official document — MDCG 2020-3](https://health.ec.europa.eu/system/files/2020-03/mdcg_2020_3_guidance_significant_changes_en_0.pdf)

European Commission website.

- Category

  MDCG guidance

- Market

  European Union

- Applicable classes

  Class I medical device, Class IIa medical device, Class IIb medical device, Class III medical device

## In practice

A significant change triggers a new conformity assessment. Examples: change of material, new indication, critical software change.

## See where this text lands in your roadmap

Normiq places every deadline in your device's roadmap, with the steps that lead to it. Free 7-day trial.

[Start the free trial](https://normiq.app/signup)

## In the same category

- [MDCG 2021-24](https://normiq.app/en/regulations/mdcg-2021-24)
- [MDCG 2020-13](https://normiq.app/en/regulations/mdcg-2020-13)
- [MDCG 2019-11](https://normiq.app/en/regulations/mdcg-2019-11)
